NDC 0407-0778-02 - HYPAQUE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0407-0778
- Requested NDC
- 0407-0778-02
- Package NDCs from labels
- 0407-0778-02
- Manufacturer
- Amersham Health Inc.
- Effective date
- 2006-04-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYPAQUE - Amersham Health Inc. | Amersham Health Inc. | 2006-04-13 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0407-0778-02 | HYPAQUE | 200 mL in 1 BOTTLE | INJECTION, SOLUTION | 200 | 1 | |
| 0407-0778-02 | HYPAQUE | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Diatrizoate Meglumine | ACTIVE INGREDIENT | 3X9MR4N98U | HYPAQUE (DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 | |
| Diatrizoate Sodium | ACTIVE INGREDIENT | V5403H8VG7 | HYPAQUE (DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 | |
| Diatrizoate | ACTIVE MOIETY | HYPAQUE (DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 | ||
| Iodine | INACTIVE INGREDIENT | 9679TC07X4 | HYPAQUE (DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM) INJECTION, SOLUTION [AMERSHAM HEALTH INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0AAAA03E-B258-45EC-89C8-06E1353F57EF | 0AAAA03E-B258-45EC-89C8-06E1353F57EF | 2006-04-13 | Warnings, Adverse reactions | 0AAAA03E-B258-45EC-89C8-06E1353F57EF 0AAAA03E-B258-45EC-89C8-06E1353F57EF |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.